SC II Acquisition Files for $150M IPO

Dow Jones
10/17
 

By Stephen Nakrosis

 

SC II Acquisition, a blank-check company affiliated with Nukkleus, filed for a $150 million initial public offering.

The company said its sponsor, SC Capital II Sponsor, is an indirect subsidiary of Nukkleus which is a financial technology company whose shares trade on the Nasdaq under the symbol NUKK.

SC II said Menachem Shalom, its chief executive and a director, has been CEO of Nukkleus since September 2024. Shalom is also CEO and a director of special purpose acquisition company Kochav Defense Acquisition, which completed its IPO in May.

Asaf Yarkoni, SC II's chief financial officer, has been CFO of Kamari Pharma since 2021, and is also CFO of Kochav Defense Acquisition.

SC II said it hasn't selected a business combination target, and may pursue an acquisition opportunity in any business, industry, sector or geographical location.

The company applied to list its units on The Nasdaq Global Market under the symbol SCIIU.

 

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

October 16, 2025 18:14 ET (22:14 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10